A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
PHASE3
This study will assess the safety and efficacy of ixekizumab (LY2439821) co...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
PHASE2
This is a Phase II, randomized, active-controlled, double-blind, double-dum...
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
PHASE3
To evaluate the efficacy of CP-690,550 as compared to etanercept and the sa...